A study on the prevention of oral cancer metastasis by targeting a transcription factor NF-κB and protease
A study on the prevention of oral cancer metastasis by targeting a transcription factor NF-κB and protease
批准号:
11671993
负责人:
IKEBE Tetsuro
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We examined a validity of NF-κB targeting therapy of oral cancer. Firstly, the involvement of matrix metalloproteinase-9 (MMP-9) in cancer invasion and metastasis was studied in the biopsy specimens of oral cancer patients. Secondly, in order to block the capability of oral cancer cells to produce MMP-9, we attempted to inhibit the activation of a transcription factor NF-κB through various methods.(1) We examined a gelatinolytic activity of MMP-9 in the biopsy specimens of 57 cases of oral squamous cell carcinoma by gelatin zymography. The same specimens were also stained immunohistochemically by anti-MMP-9 antibody. The gelatinolytic activity of MMP-9 in each case correlated with the immunohistochemical staining degree of MMP-9. The gelatin zymographic analysis of 57 cases revealed that the gelatinolytic activity of MMP-9 in biopsy specimens statistically correlated with histopathological invasiveness of oral cancer, suggesting that MMP-9 expression contributes to the invasion and met … More astasis of oral cancer.(2) We found that the MMP-9 expression of cultured oral squamous cell carcinoma cell lines was inhibited by dexamethasone (DEX) and interleukin-4 (IL-4). DEX and IL-4 inhibited the conversion from MMP-9 precursor to active form of MMP-9 by inhibiting the gene expression of urokinase type plasminogen activator (uPA). The activation of a transcription factor NF-κB, which can activate gene expressions of MMP-9 and uPA, was also inhibited by DEX and IL-4. Therefore, DEX and IL-4 are likely to target NF-κB to inhibit the gene expression and activation of MMP-9.(3) Early-passage normal human fibroblasts can express normal size of NF-κB while the molecular size of NF-κB of late-passage fibroblasts was reduced to 70-80 kD.The senescence of normal cells may induce the intracellular NF-κB-degrading protease(s). In contrast, tumor cells can express normal NF-κB molecule stably evev after 100 passage.(4) The expression vectors of superreppressor IκBα and dominant negative IκBα kinases (IKK kinases) have been formed. We are now transtecting the expression vectors into oral cancer cells and examining the effects of these vectors on MMP-9 expression.In conclusion, NF-κB-targeting therapy may be useful to prevent invasion and metastasis of oral cancer. Less
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Ikebe,T.,Shinohara,M.,Takeuchi,H.,Beppu,M.,Kurahara,S.,Nakamura,S.その他: "Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer"Clinical & Experimental Metastasis. 17. 315-323 (1999)
Ikebe, T.、Shinohara, M.、Takeuchi, H.、Beppu, M.、Kurahara, S.、Nakamura, S. 等人:“肿瘤组织中基质金属蛋白酶的明胶分解活性与口腔癌的侵袭性相关”临床与实验转移。17. 315-323 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A study on the response of oral mucosa to reactive oxygen species and its application to the prevention against oral cancer.
-
批准号:23390468
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.9万
-
财政年份:2011
-
负责人:IKEBE Tetsuro
-
依托单位:
A study on mevalonic acid pathway-targeting therapy to recovery osteoclasts damaged with bisphosphonate
-
批准号:23659957
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.08万
-
财政年份:2011
-
负责人:IKEBE Tetsuro
-
依托单位:
A study on the diagnostic method for detecting the molecular injury occurring in tongue mucosa under environmental stress
-
批准号:20592383
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2008
-
负责人:IKEBE Tetsuro
-
依托单位:
A study on the senescence-inducing therapy to oral cancer by targeting IκB kinase
-
批准号:13672104
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2001
-
负责人:IKEBE Tetsuro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
SDC1通过MMP11+CAF的细胞外基质重塑促进子宫颈癌化学免疫联合治疗耐药的机制研究
-
批准号:JCZRQNB202600504
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于“大气下陷”理论探讨升陷汤调控IL-17A/IL-17RA信号轴抑制MMP-2/MMP-9表达抗心衰大鼠心肌纤维化的作用机制
-
批准号:2026JJ80502
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王雪
-
依托单位:
生殖支原体感染以MMP28为枢纽介导细胞外基质重塑及组织损伤的机制研究
-
批准号:2026JJ80225
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭湘芳
-
依托单位:
CMA/溶酶体轴失衡驱动的MMP13核转位及转录调控在骨关节炎中的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:徐瑞菱
-
依托单位:
脾脏巨噬细胞糖酵解重编程促进细胞活化及MMP9表达介导川崎病炎症反应和冠状动脉病变的机制研究
-
批准号:JCZRLH202601362
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
Er - Nd:YAG双激光联合治疗种植体周围炎前后龈沟液MMP-8、IL-Iβ细胞因子变化与临床疗效关系研究
-
批准号:2026JJ82235
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曾婷雯
-
依托单位:
ADAM17通过调控MMP21促进肝细胞癌进展和M2型巨噬细胞极化
-
批准号:2026JJ82501
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:向宇琦
-
依托单位:
RSV非结构蛋白“劫持“宿主表观调控酶激活MMP-9转录致血脑屏障损伤及丙戊酸靶向干预研究
-
批准号:2026JJ50575
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭宇蓉
-
依托单位:
细菌纤维素复合敷料的电响应设计及其调控创面MMP-9/TIMP-1 通路促烧伤创面愈合机制研究
-
批准号:2026JJ82603
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吴迎
-
依托单位:
溴莫尼定通过cAMP/PKA/CREB轴调控MMP-2表达延缓近视眼轴增长的机制研究
-
批准号:2026JJ70126
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:向爱群
-
依托单位: